Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Matrix protein mutated recombinant vesicular stomatitis virus serving as porcine vaccine vector

A technology of vesicular stomatitis and matrix protein, applied in antiviral agents, medical preparations containing active ingredients, antibody medical components, etc., can solve oral vesicular lesions, animal hindlimb paralysis, highly pathogenic lethality, etc. problem, achieve the effect of reducing pathogenicity, direct experimental results, and stimulating antiviral humoral immune response

Inactive Publication Date: 2014-05-07
SHANGHAI JIAO TONG UNIV
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

First of all, mice are not the natural host of VSV, and usually do not show significant pathogenicity, but under experimental conditions, artificial inoculation, especially high-dose nasal drip, can cause them to become diseased; VSV is an arbovirus, In bovine animals such as pigs and cattle, VSV can be transmitted through contact routes and exhibit high pathogenicity and even lethality; secondly, VSV shows neurotropism in mice, which can cause hindlimb paralysis of animals, while in pigs and other natural On the host, it mainly exhibits epitheliophilia, which can cause severe vesicular lesions in the mouth and other places

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Matrix protein mutated recombinant vesicular stomatitis virus serving as porcine vaccine vector
  • Matrix protein mutated recombinant vesicular stomatitis virus serving as porcine vaccine vector
  • Matrix protein mutated recombinant vesicular stomatitis virus serving as porcine vaccine vector

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0038] In this embodiment, based on the VSV Indiana strain (VSV IND ) Genome sequence constructed wild-type representative (VSV XN2 ) and the recombinant virus VSVΔM51 with the 51st methionine deletion in the M protein were prepared and preserved by our laboratory (Xinkui Fang, Shikuan Zhang, Xiaodong Sun, Jinjin Li, Tao Sun. Evaluation of attenuated VSVs with mutated M or / and G proteins as vaccine vectors.Vaccine.2012, 30(7):1313-1321.), VSV virus expressing green fluorescent protein GFP (VSV-GFP) was also prepared and preserved by our laboratory as described in the literature. (Schnell MJ, Buonocore L, Kretzschmar E, Johnson E, Rose JK. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A. 1996, 93(21): 11359-65) VSV XN2 and VSVΔM51 virus genome structure such as figure 1 shown. BHK 21 , Vero cells were purchased from the Shanghai Cell Bank of the Chinese Academy of Scien...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a matrix protein mutated recombinant vesicular stomatitis virus serving as a porcine vaccine vector. The vaccine vector is a recombinant virus VSV (vesicular stomatitis virus) delta M51. The invention also provides a kit for detecting the specific M antibody in porcine serum. The using method of the kit comprises the following steps: establishing an ELISA method by utilizing high-purity M protein prepared by recombinant expression to detect the level of the specific M antibody in porcine serum which is inoculated with VSV delta M51 virus. The invention firstly provides the variant virus strain (VSV delta M51) of which the 51st arginine of the matrix protein of an VSV critical virulence factor serving as a candidate VSV virus strain with application values, provides a systematic evaluation to the pathogenicity of VSV delta M51 on pigs for the first time at home and abroad, and provides basis to VSV delta M51 serving as the vaccine vector.

Description

technical field [0001] The invention relates to a recombinant vesicular stomatitis virus with matrix protein mutation as a porcine vaccine carrier. Background technique [0002] Vesicular stomatitis (VS) is an acute highly contagious disease caused by vesicular stomatitis virus (VSV). Horses, cattle, pigs and other animals are more susceptible, and sheep and goats are also susceptible. Can be infected. Clinically, blisters occur on the epithelium of the tongue, lips, oral mucosa, nipples, and hooves as the main feature. Vesicular stomatitis is clinically difficult to distinguish from infectious diseases such as foot-and-mouth disease (FMD), vesicular disease of swine (SV), and vesicular eruption of swine (VES). In my country, vesicular stomatitis is an exotic animal disease, and no large-scale outbreak has been reported. It is listed as a second-class disease in the country's entry and exit animal quarantine objects. However, with my country's entry into the WTO, the inter...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/205G01N33/569A61P31/14
Inventor 孙涛方心葵
Owner SHANGHAI JIAO TONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products